期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
1,3-Bis(2-chloroethyl)-1-nitrosourea enhances the inhibitory effect of Resveratrol on 5-fluorouracil sensitive/resistant colon cancer cells 被引量:4
1
作者 Dipon Das Ranjan Preet +2 位作者 Purusottam Mohapatra Shakti Ranjan Satapathy Chanakya Nath Kundu 《World Journal of Gastroenterology》 SCIE CAS 2013年第42期7374-7388,共15页
AIM:To study the mechanism of 5-fluorouracil(5-FU)resistance in colon cancer cells and to develop strategies for overcoming such resistance by combination treatment.METHODS:We established and characterized a 5-FU resi... AIM:To study the mechanism of 5-fluorouracil(5-FU)resistance in colon cancer cells and to develop strategies for overcoming such resistance by combination treatment.METHODS:We established and characterized a 5-FU resistance(5-FU-R)cell line derived from continuous exposure(25μmol/L)to 5-FU for 20 wk in 5-FU sensitive HCT-116 cells.The proliferation and expression of different representative apoptosis and anti-apoptosis markers in 5-FU sensitive and 5-FU resistance cells were measured by the MTT assay and by Western blotting,respectively,after treatment with Resveratrol(Res)and/or 1,3-Bis(2-chloroethyl)-1-nitrosourea(BCNU).Apoptosis and cell cycle arrest was measured by 4',6'-diamidino-2-phenylindole hydrochloride staining and fluorescence-activated cell sorting analysis,respectively.The extent of DNA damage was measured by the Comet assay.We measured the visible changes in the DNA damage/repair cascade by Western blotting.RESULTS:The widely used chemotherapeutic agents BCNU and Res decreased the growth of 5-FU sensitive HCT-116 cells in a dose dependent manner.Combined application of BCNU and Res caused more apoptosis in5-FU sensitive cells in comparison to individual treatment.In addition,the combined application of BCNU and Res caused a significant decrease of major DNA base excision repair components in 5-FU sensitive cells.We established a 5-FU resistance cell line(5-FU-R)from 5-FU-sensitive HCT-116(mismatch repair deficient)cells that was not resistant to other chemotherapeutic agents(e.g.,BCNU,Res)except 5-FU.The 5-FU resistance of 5-FU-R cells was assessed by exposure to increasing concentrations of 5-FU followed by the MTT assay.There was no significant cell death noted in5-FU-R cells in comparison to 5-FU sensitive cells after5-FU treatment.This resistant cell line overexpressed anti-apoptotic[e.g.,AKT,nuclear factorκB,FLICE-like inhibitory protein),DNA repair(e.g.,DNA polymerase beta(POL-β),DNA polymerase eta(POLH),protein Flap endonuclease 1(FEN1),DNA damage-binding protein 2(DDB2)]and 5-FU-resistance proteins(thymidylate synthase)but under expressed pro-apoptotic proteins(e.g.,DAB2,CK1)in comparison to the parental cells.Increased genotoxicity and apoptosis were observed in resistant cells after combined application of BCNU and Res in comparison to untreated or parental cells.BCNU increased the sensitivity to Res of 5-FU resistant cells compared with parental cells.Fifty percent cell death were noted in parental cells when 18μmol/L of Res was associated with fixed concentration(20μmol/L)of BCNU,but a much lower concentration of Res(8μmol/L)was needed to achieve the same effect in 5-FU resistant cells.Interestingly,increased levels of adenomatous polyposis coli and decreased levels POL-β,POLH,FEN1 and DDB2 were noted after the same combined treatment in resistant cells.CONCLUSION:BCNU combined with Res exerts a synergistic effect that may prove useful for the treatment of colon cancer and to overcome drug resistance. 展开更多
关键词 5-fluorouracil 1 3-Bis(2-chloroethyl)-1-nitrosourea RESVERATROL COLON cancer Combination therapy
下载PDF
Synthesis and Crystal Structure of N1-(2-(4-Bromo-2-nitrophenoxy)-2-dimethyl acyloxymethyl)-5-fluorouracil
2
作者 贾忠 李靖 +5 位作者 张阳 赵静思 席娜 胡春红 胡敏敏 贺殿 《Chinese Journal of Structural Chemistry》 SCIE CAS CSCD 2016年第7期1047-1053,共7页
The title compound N1-(2-(4-bromo-2-nitrophenoxy)-2-dimethyl acyloxymethyl)-5-fluorouracil(C15H13BrFN3O7, Mr = 446.19) was synthesized and structurally characterized by ^1H-NMR, -(13)C-NMR, ESI-MS and single-c... The title compound N1-(2-(4-bromo-2-nitrophenoxy)-2-dimethyl acyloxymethyl)-5-fluorouracil(C15H13BrFN3O7, Mr = 446.19) was synthesized and structurally characterized by ^1H-NMR, -(13)C-NMR, ESI-MS and single-crystal X-ray diffraction. The compound crystallizes in triclinic, space group P1, with a = 8.3325(6), b = 10.1808(13), c = 11.8194(16) A, α = 73.194(12), β= 72.351(9), γ = 89.509(8)o, V = 911.2(2) A^3, Z = 2, T = 300.79(10) K, μ(Cu Kα) = 3.578 mm^-1, Dc = 1.626 g/cm3, F(000) = 448.0, GOF = 1.060, 5723 reflections measured(8.232≤2θ≤139.592°), 3339 unique(Rint = 0.0184, Rsigma = 0.0254) which were used in all calculations. The final R = 0.0517(I 〉 2s(I)) and wR = 0.1494(all data). Hydrogen bonds and π-π interactions together stabilize the structure of the molecule. The preliminary biological test shows that the title compound has good antitumor activity against A549 in vitro and lower toxicity to normal cells. 展开更多
关键词 crystal structure synthesis N1-(2-(4-bromo-2-nitrophenoxy)-2-dimethyl acyloxymethyl)-5-fluorouracil antitumor activity
下载PDF
新型含环状α-羟基膦酸酯的N^1-(四氢呋喃-2-基)-5-氟尿嘧啶衍生物的合成 被引量:3
3
作者 石德清 魏佳 谭效松 《有机化学》 SCIE CAS CSCD 北大核心 2005年第12期1602-1605,共4页
通过N1-(2-呋喃烷基)-N3-羟乙基-5-氟尿嘧啶的Moffatt氧化,再与亚磷酸酯的加成反应合成得到8个新型含环状α-羟基膦酸酯的N1-(四氢呋喃-2-基)-5-氟尿嘧啶衍生物,采用IR,1HNMR,31PNMR,MS和元素分析对其结构进行了表征.
关键词 5-氟尿嘧啶 α-羟基膦酸酯 抗肿瘤药物
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部